Chang Joshua, Rabenn Rachel, Parikh Aditi, Wu Chen-Han Wilfred
Department of Genetics and Genome Sciences, Department of Urology, Case Western Reserve University School of Medicine and University Hospitals, Cleveland, OH, United States.
Cancer and General Genetics, Center for Human Genetics, University Hospitals, Cleveland, OH, United States.
Cancer Genet. 2025 Sep;296-297:200-204. doi: 10.1016/j.cancergen.2025.07.013. Epub 2025 Jul 24.
DICER1 syndrome is a tumor-predisposition disorder caused by a germline pathogenic variant in DICER1. Pathogenic variants of DICER1 are the monogenic cause of various tumors including pleuropulmonary blastoma (PPB), ovarian sex cord-stromal tumors, and multinodular goiters. We present a family with a novel DICER1 pathogenic variant c.5528-2del who presents with development of isolated thyroid goiters/follicular adenoma. A 44 year old female presents with a past medical history of total thyroidectomy along with her 14-year-old son with a past history of multinodular thyroid goiter confirmed as multifocal follicular adenoma with papillary architecture and her 12-year-old daughter with a past history of multinodular thyroid goiter confirmed as diffuse nodular thyroid hyperplasia. No additional DICER1 syndrome presentations were observed. A genetics panel revealed that the mother, the 14-year-old son, and the 12-year-old daughter share a heterozygous DICER1 c.5528-2del variant, which has not been previously reported. In addition to our direct clinical observations from this family, genetic analysis via in silico prediction models, segregation analysis, and ACMG classification support this variant to be pathogenic. Given the absence of other DICER1 syndrome manifestations through human genetics evidence, this variant may be specifically associated with isolated multinodular goiters/follicular adenoma. Our findings contribute to the expanding genotype-phenotype correlation in DICER1 syndrome, providing new insights into its variable clinical presentation. Since not all variants are identical, reporting of these observations will advance precision medicine and benefit future patients through more accurate diagnosis, prognosis and personalized management strategies.
DICER1综合征是一种由DICER1基因种系致病性变异引起的肿瘤易感性疾病。DICER1的致病性变异是包括胸膜肺母细胞瘤(PPB)、卵巢性索间质肿瘤和多结节性甲状腺肿在内的各种肿瘤的单基因病因。我们报告了一个携带新型DICER1致病性变异c.5528-2del的家系,该家系表现为孤立性甲状腺肿/滤泡性腺瘤。一名44岁女性有甲状腺全切术病史,她14岁的儿子有多结节性甲状腺肿病史,经确诊为具有乳头状结构的多灶性滤泡性腺瘤,她12岁的女儿有多结节性甲状腺肿病史,经确诊为弥漫性结节性甲状腺增生。未观察到其他DICER1综合征表现。基因检测显示,母亲、14岁的儿子和12岁的女儿共享一个杂合的DICER1 c.5528-2del变异,该变异此前未见报道。除了我们对这个家系的直接临床观察外,通过计算机预测模型、分离分析和ACMG分类进行的基因分析支持该变异具有致病性。鉴于通过人类遗传学证据未发现其他DICER1综合征表现,该变异可能与孤立性多结节性甲状腺肿/滤泡性腺瘤特异性相关。我们的研究结果有助于扩大DICER1综合征的基因型-表型相关性,为其多变的临床表现提供新的见解。由于并非所有变异都是相同的,报告这些观察结果将推动精准医学发展,并通过更准确的诊断、预后和个性化管理策略使未来患者受益。